A randomized phase 2 study of the thrombospondin-mimetic peptide ABT-510 in patients with previously untreated advanced renal cell carcinomaScot Ebbinghaus, Robert A. Figlin, Nizar M. Tannir et al.|Journal of Clinical Oncology|2005Cited by 9